1. Toll-Like Receptor 9 Agonists in Cancer


    Lilit Karapetyan et al, 2020, OncoTargets and Therapy CrossRef
  2. CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
    Zhongkun Zhang et al, 2021, Pharmaceutics CrossRef
  3. The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo
    Wenming Feng et al, 2022, Journal of Oncology CrossRef